TARS

NASDAQ HEALTHCARE

Tarsus Pharmaceuticals Inc

$70.03

$1.83 (+2.68%)

Live quote

52w: $53.89 – $91.53

Loading chart…

P/E Ratio—

P/B Ratio8.63

EV/EBITDA—

Debt/Equity—

ROE-19.16%

ROIC—

Revenue Growth146.71%

Gross Margin—

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Own TARS? Track it here.

Create a free account to add TARS to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account